Beyond Framingham: Cardiovascular risk profiling in ESRD

被引：17
|
作者：
McClellan, WM [1 ]
Chertow, GM [1 ]
机构：
[1] Emory Univ, Div Renal, Georgia Med Care Fdn, Atlanta, GA 30329 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 06期
关键词：
D O I：
10.1681/ASN.2005040415
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1539 / 1541
页数：3
相关论文
共 50 条
  • [31] Pulse wave analysis and the Framingham risk functions for cardiovascular risk assessment
    Williams, KC
    Yeo, KR
    Wilson, C
    Yeo, WW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 648 - 649
  • [32] Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study
    Peloso, Gina M.
    Beiser, Alexa S.
    Satizabal, Claudia L.
    Xanthakis, Vanessa
    Vasan, Ramachandran S.
    Pase, Matthew P.
    Destefano, Anita L.
    Seshadri, Sudha
    NEUROLOGY, 2020, 95 (10) : E1341 - E1350
  • [33] The risk of cardiovascular disease following breast cancer by Framingham risk score
    Sofie A. M. Gernaat
    Jolanda M. A. Boer
    Desiree H. J. van den Bongard
    Angela H. E. M. Maas
    Carmen C. van der Pol
    Rhodé M. Bijlsma
    Diederick E. Grobbee
    Helena M. Verkooijen
    Petra H. Peeters
    Breast Cancer Research and Treatment, 2018, 170 : 119 - 127
  • [34] Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population
    Stec, JJ
    Silbershatz, H
    Tofler, GH
    Matheney, TH
    Sutherland, P
    Lipinska, I
    Massaro, JM
    Wilson, PFW
    Muller, JE
    D'Agostino, RB
    CIRCULATION, 2000, 102 (14) : 1634 - 1638
  • [35] Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
    Tzoulaki, Ioanna
    Liberopoulos, George
    Ioannidis, John P. A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (21): : 2345 - 2352
  • [36] Re: Clinical Usefulness of the Framingham Cardiovascular Risk Profile beyond Its Statistical Performance: The Tehran Lipid and Glucose Study
    Janes, Holly
    Pepe, Margaret
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 (08) : 864 - 864
  • [37] Risk factors and underlying cardiovascular diseases in incident ESRD patients
    Di Benedetto, A
    Marcelli, D
    D'Andrea, A
    Cice, G
    D'Isa, S
    Cappabianca, F
    Pacchiano, G
    D'Amato, R
    Oggero, AR
    Bonanno, D
    Pergamo, O
    Calabrò, R
    JOURNAL OF NEPHROLOGY, 2005, 18 (05) : 592 - 598
  • [38] Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases
    Rysz, Jacek
    Franczyk, Beata
    Lawinski, Janusz
    Gluba-Brzozka, Anna
    ANTIOXIDANTS, 2020, 9 (11) : 1 - 24
  • [39] ZAG-a novel biomarker for cardiovascular risk in ESRD patients?
    Schmitt, Roland
    KIDNEY INTERNATIONAL, 2018, 94 (05) : 858 - 860
  • [40] Risk Stratification and Selection for Statin Therapy: Going Beyond Framingham
    Fitchett, David H.
    Mancini, G. B. John
    Gregoire, Jean
    Anderson, Todd
    McPherson, Ruth
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (06) : 667 - 670
12345